Increased nuchal translucency as a prenatal manifestation of congenital adrenal hyperplasia
暂无分享,去创建一个
C. Rodeck | K. Kalache | E. Jauniaux | G. Rumsby | B. Masturzo | J. Hyett
[1] L. Chitty,et al. Smith–Lemli–Opitz syndrome presenting with persisting nuchal oedema and non‐immune hydrops , 1999, Prenatal diagnosis.
[2] N. Montenegro,et al. Screening for chromosomal abnormalities at 10–14 weeks: the role of ductus venosus blood flow , 1998, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[3] K. Nicolaides,et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation , 1998, The Lancet.
[4] R. Snijders,et al. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10–14 weeks of gestation , 1998, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[5] E. Jauniaux. Diagnosis and management of early non‐immune hydrops fetalis , 1997, Prenatal diagnosis.
[6] E. Haan,et al. FIRST‐TRIMESTER DIAGNOSIS OF SMITH–LEMLI–OPITZ SYNDROME , 1997, Prenatal diagnosis.
[7] K. Nicolaides,et al. Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses. , 1997, American journal of medical genetics.
[8] A. Lin,et al. Cardiovascular malformations in Smith-Lemli-Opitz syndrome. , 1997, American journal of medical genetics.
[9] F. Barany,et al. Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees. , 1996, Human molecular genetics.
[10] K. Nicolaides,et al. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 1l–13 weeks of gestation , 1996, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[11] K. Nicolaides,et al. Increased first trimester nuchal translucency as a prenatal manifestation of Smith-Lemli-Opitz syndrome. , 1995, American journal of medical genetics.
[12] M. New,et al. Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene. , 1995, The Journal of clinical endocrinology and metabolism.
[13] J. Hobbins,et al. Transvaginal ultrasonography and transabdominal embryoscopy in the first-trimester diagnosis of Smith-Lemli-Opitz syndrome, type II. , 1994, American journal of obstetrics and gynecology.
[14] J. Mandell,et al. Masculinization of female fetuses with congenital adrenal hyperplasia may already be present at 18 weeks. , 1994, American Journal of Obstetrics and Gynecology.
[15] M. Forest,et al. Prenatal diagnosis and treatment of 21-hydroxylase deficiency , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[16] K. Fujieda,et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 1988, Pediatrics.
[17] I. Hughes,et al. Early diagnosis of salt-losing congenital adrenal hyperplasia in a newborn boy. , 1977, Canadian Medical Association journal.